These are 2 of my top stocks to buy in April 

These are Manika Premsingh’s two top stocks because of their strong credentials combined with their current subdued share prices.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As a long-term investor, I think there is never a bad time to invest in a good stock. But some times maybe better than others. It is for this reason that these two FTSE 100 stocks are on my radar for April:

#1. AstraZeneca: overdue comeback for this top stock 

The Covid-19 vaccination star, AstraZeneca (LSE: AZN), has seen quite the fall in the recent days. Soon after vaccine discoveries, the company’s pricey shares were suddenly less attractive to investors. 

When question marks started appearing about both the efficacy of the vaccine and its side-effects, investor confidence in the share was probably shaken further. From its all-time highs in July last year to earlier this month, the AstraZeneca share price had dropped more than 27%.

But I think that the worst may just be over for the share for two reasons: 

1) It releases results for the first quarter of this year in April. If the update conforms to the positive growth trends seen in recent times, I think it will underline the value of AstraZeneca to investors irrespective of vaccine-related challenges.

2) Its earnings ratio has become relatively competitive with the recent price decline. It is still high, at 41 times. But it is lower than that for other FTSE 100 safe-stocks or defensives like water and sewage services provider Severn Trent and hygienist and pest-control provider Rentokil Initial, whose ratios are closer to 50 times. 

The AstraZeneca share price has already started rising, and barring any untoward developments, I reckon it will strengthen its position in April, making it a top stock for me.

The one concern I have about the AstraZeneca stock is the potential reputational damage it can suffer if questions on its Covid-19 vaccine persist. 

#2. Royal Dutch Shell: returning to profits

2020 could not have been worse for FTSE 100 oil biggies like Royal Dutch Shell (LSE: RDSB) and BP. But it appears that they are more than ready to make up for last year’s setbacks now. 

Even with some recent fall, crude oil prices have still made significant gains since November last year. With the outlook for travel improving and the easing of lockdowns, oil prices should stay elevated, which is positive for Shell.

With improved market conditions, I am also hopeful that it will increase its dividend, which in turn should be positive for its share price too. I will be looking out for its dividend update when it releases its first-quarter results for 2021 next month. For its improved prospects, Royal Dutch Shell is one of the top stocks for me for next month. 

There are risks to buying it, though, for the long-term. The fossil fuels industry is going through a sea change. We do not know if the oil giants will be able to pull off the transition, so an investment into Shell will need to be reconsidered over time.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh owns shares of AstraZeneca, BP, Rentokil Initial, and Royal Dutch Shell B. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »